JP2007536933A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007536933A5 JP2007536933A5 JP2007513283A JP2007513283A JP2007536933A5 JP 2007536933 A5 JP2007536933 A5 JP 2007536933A5 JP 2007513283 A JP2007513283 A JP 2007513283A JP 2007513283 A JP2007513283 A JP 2007513283A JP 2007536933 A5 JP2007536933 A5 JP 2007536933A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cell
- antibody
- pharmaceutical composition
- immunoglobulin chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56989204P | 2004-05-10 | 2004-05-10 | |
| US60/569,892 | 2004-05-10 | ||
| PCT/US2005/016357 WO2005110475A2 (en) | 2004-05-10 | 2005-05-10 | Antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011121078A Division JP2011200247A (ja) | 2004-05-10 | 2011-05-30 | 抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007536933A JP2007536933A (ja) | 2007-12-20 |
| JP2007536933A5 true JP2007536933A5 (cg-RX-API-DMAC7.html) | 2008-06-26 |
| JP5623690B2 JP5623690B2 (ja) | 2014-11-12 |
Family
ID=35394680
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007513283A Expired - Lifetime JP5623690B2 (ja) | 2004-05-10 | 2005-05-10 | 抗体 |
| JP2011121078A Pending JP2011200247A (ja) | 2004-05-10 | 2011-05-30 | 抗体 |
| JP2014003463A Pending JP2014094010A (ja) | 2004-05-10 | 2014-01-10 | 抗体 |
| JP2014156064A Withdrawn JP2014223084A (ja) | 2004-05-10 | 2014-07-31 | 抗体 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011121078A Pending JP2011200247A (ja) | 2004-05-10 | 2011-05-30 | 抗体 |
| JP2014003463A Pending JP2014094010A (ja) | 2004-05-10 | 2014-01-10 | 抗体 |
| JP2014156064A Withdrawn JP2014223084A (ja) | 2004-05-10 | 2014-07-31 | 抗体 |
Country Status (27)
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7744888B2 (en) | 2001-08-03 | 2010-06-29 | Abgenomics Cooperatief U.A. | Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies |
| US20040116333A1 (en) * | 2001-08-03 | 2004-06-17 | Rong-Hwa Lin | Modulators of P-selectin glycoprotein ligand 1 |
| MY148646A (en) | 2004-05-10 | 2013-05-15 | Abgenomics Cooperatief Ua | Anti-psgl-1 antibodies |
| BRPI0510561A (pt) * | 2004-05-11 | 2007-11-20 | Abgenomics Corp | epìtopos que induzem morte de célula t |
| WO2007067984A2 (en) * | 2005-12-09 | 2007-06-14 | Wyeth | Neutralizing antibodies against primate psgl-1 and uses therefor |
| CA2741798A1 (en) * | 2008-10-28 | 2010-05-06 | Shionogi & Co., Ltd. | Anti-muc1 antibody |
| TWI659474B (zh) * | 2008-10-31 | 2019-05-11 | Semiconductor Energy Laboratory Co., Ltd. | 半導體裝置及其製造方法 |
| GB0822011D0 (en) * | 2008-12-02 | 2009-01-07 | Queen Mary & Westfield College | Treatment |
| IN2015DN02826A (cg-RX-API-DMAC7.html) * | 2009-09-03 | 2015-09-11 | Merck Sharp & Dohme | |
| WO2012000094A1 (en) * | 2010-06-30 | 2012-01-05 | Mount Sinai Hospital | REAGENTS AND METHODS FOR DIAGNOSING CONDITIONS ASSOCIATED WITH HYDROXYLATED HIF 1-α |
| ES2387156B1 (es) * | 2010-12-01 | 2013-07-04 | Universidad Autónoma de Madrid | Uso de psgl-1 para el tratamiento de enfermedades inflamatorias y autoinmunes |
| EP2718325A4 (en) * | 2011-06-13 | 2015-03-11 | ABGENOMICS COöPERATIEF U A | ANTI-PSGL-1 ANTIBODIES AND USES THEREOF |
| WO2013057096A1 (en) | 2011-10-17 | 2013-04-25 | Westfaelische Wilhelms-Universitaet Muenster | Assessment of pml risk and methods based thereon |
| PL3489261T3 (pl) | 2012-08-24 | 2021-08-16 | The Regents Of The University Of California | Przeciwciała i szczepionki do stosowania w leczeniu nowotworów z ekspresją ROR1 i w hamowaniu przerzutu |
| TWI595007B (zh) * | 2012-09-10 | 2017-08-11 | Neotope Biosciences Ltd | 抗mcam抗體及相關使用方法 |
| US10988528B2 (en) * | 2015-08-13 | 2021-04-27 | New York University | Antibody-based molecules specific for the truncated ASP421 epitope of Tau and their uses in the diagnosis and treatment of tauopathy |
| WO2017120534A1 (en) * | 2016-01-08 | 2017-07-13 | Bioalliance C.V. | Tetravalent anti-psgl-1 antibodies and uses thereof |
| WO2017214941A1 (zh) * | 2016-06-16 | 2017-12-21 | 毛侃琅 | 一种提升SelP基因表达水平的慢病毒载体及其应用 |
| KR20230047507A (ko) | 2016-06-27 | 2023-04-07 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 암 치료 조합 |
| KR20250159733A (ko) | 2017-01-11 | 2025-11-11 | 브리스톨-마이어스 스큅 컴퍼니 | Psgl-1 길항제 및 그의 용도 |
| PE20250933A1 (es) | 2017-03-14 | 2025-04-02 | Five Prime Therapeutics Inc | Anticuerpos de union a vista a ph acido |
| SG11202008593PA (en) | 2018-03-21 | 2020-10-29 | Five Prime Therapeutics Inc | ANTIBODIES BINDING TO VISTA AT ACIDIC pH |
| AU2019301120A1 (en) | 2018-07-11 | 2021-02-25 | Bristol-Myers Squibb Company | Antibodies binding to VISTA at acidic pH |
| KR20250024129A (ko) | 2018-07-20 | 2025-02-18 | 피에르 파브르 메디카먼트 | Vista의 수용체 |
| KR20220042055A (ko) * | 2019-06-04 | 2022-04-04 | 베르조 테라퓨틱스, 아이엔씨. | 골수성 세포 염증성 표현형을 조절하기 위한 항-psgl-1 조성물 및 방법, 그리고 이의 용도 |
| JP7821733B2 (ja) * | 2020-01-22 | 2026-02-27 | 上海森輝医薬有限公司 | エリブリン誘導体の薬物複合体、その調製方法及びその医薬的応用 |
| JP2024540484A (ja) * | 2021-11-17 | 2024-10-31 | アルトゥルバイオ, インコーポレイテッド | 抗psgl-1抗体をjak阻害剤と組み合わせて使用してt細胞媒介性炎症性疾患またはがんを治療する方法 |
| TW202540180A (zh) * | 2023-11-17 | 2025-10-16 | 美商美國全心醫藥生技股份有限公司 | 抗psgl-1抗體及其用途 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US4704692A (en) | 1986-09-02 | 1987-11-03 | Ladner Robert C | Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides |
| US5378464A (en) * | 1989-03-08 | 1995-01-03 | Board Of Regents Of The University Of Oklahoma | Modulation of inflammatory responses by administration of GMP-140 or antibody to GMP-140 |
| US5464778A (en) * | 1989-03-08 | 1995-11-07 | Board Of Regents Of The University Of Oklahoma | Glycoprotein ligand for P-selectin and methods of use thereof |
| US5690933A (en) * | 1989-05-31 | 1997-11-25 | Glaxo Wellcome Inc. | Monoclonal antibodies for inducing tolerance |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| ES2246502T3 (es) | 1990-08-29 | 2006-02-16 | Genpharm International, Inc. | Animales no humanos transgenicos capaces de producir anticuerpos heterologos. |
| US5709859A (en) * | 1991-01-24 | 1998-01-20 | Bristol-Myers Squibb Company | Mixed specificity fusion proteins |
| US6309639B1 (en) * | 1991-02-05 | 2001-10-30 | The Board Of Regents Of The University Of Oklahoma | Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand |
| US6124267A (en) * | 1991-02-05 | 2000-09-26 | Southpac Trust Internationals, Inc. | O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1 |
| US5972625A (en) * | 1991-05-06 | 1999-10-26 | The Regents Of The University Of California | Assays for inhibitors of leukocyte adhesion |
| AU673347B2 (en) | 1992-03-17 | 1996-11-07 | Novartis Ag | Genetically engineered antibodies |
| US5843707A (en) * | 1992-10-23 | 1998-12-01 | Genetics Institute, Inc. | Nucleic acid encoding a novel P-selectin ligand protein |
| RU2151612C1 (ru) * | 1992-12-01 | 2000-06-27 | Протеин Дизайн Лэбс, Инк. | Гуманизированный иммуноглобулин, специфичный для белка l-селектина человека |
| US6210671B1 (en) * | 1992-12-01 | 2001-04-03 | Protein Design Labs, Inc. | Humanized antibodies reactive with L-selectin |
| WO1994014836A1 (en) * | 1992-12-18 | 1994-07-07 | Centocor, Inc. | Peptide inhibitors of selectin binding |
| DE69415154T2 (de) * | 1993-01-25 | 1999-07-29 | Dana-Farber Cancer Institute, Inc., Boston, Mass. | Chimäre selektine erhältlich durch domänenaustauch und ihre verwendungen |
| CN1124928A (zh) * | 1993-05-04 | 1996-06-19 | 赛特尔公司 | P-选择蛋白抗体及其应用 |
| WO1995014787A1 (en) * | 1993-11-22 | 1995-06-01 | Centocor, Inc. | Peptide inhibitors of selecting binding |
| DE69630307T2 (de) | 1995-08-03 | 2004-07-15 | The Board Of Regents Of The University Of Oklahoma, Norman | O-glycaninhibitoren von selectinvermittelten entzüngen |
| US6348581B1 (en) * | 1996-10-31 | 2002-02-19 | The Dow Chemical Company | High affinity humanized anti-TAG-72 monoclonalantibodies |
| JP3248570B2 (ja) * | 1997-10-09 | 2002-01-21 | 日本電気株式会社 | 半導体装置の製造方法 |
| WO1999043353A2 (en) * | 1998-02-26 | 1999-09-02 | Boehringer Ingelheim Pharmaceuticals, Inc. | Combination anti-selectin and immunosuppressant therapy |
| CN1342085A (zh) * | 1998-10-30 | 2002-03-27 | 遗传研究所有限公司 | 通过p-选择素配体(psgl)拮抗剂抑制细胞素t细胞的分化 |
| US6696620B2 (en) | 2000-05-02 | 2004-02-24 | Epicyte Pharmaceutical, Inc. | Immunoglobulin binding protein arrays in eukaryotic cells |
| EP1289552B1 (en) * | 2000-05-19 | 2006-03-29 | The Center for Blood Research, INC. | Methods for treating hemostatic disorders by soluble p-selectin |
| CN1124928C (zh) * | 2000-07-11 | 2003-10-22 | 湛江包装材料企业有限公司 | 光降解双向拉伸聚丙烯薄膜的制造方法 |
| WO2002022820A1 (en) * | 2000-09-12 | 2002-03-21 | Genetics Institute, Llc | Inhibition of stenosis or restenosis by p-selectin antagonists |
| US20040002450A1 (en) * | 2000-12-29 | 2004-01-01 | Janette Lazarovits | Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| PL366223A1 (en) | 2000-12-29 | 2005-01-24 | Bio-Technology General Corp. | Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| US20040001839A1 (en) * | 2000-12-29 | 2004-01-01 | Avigdor Levanon | Multimers - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| US6884619B2 (en) * | 2001-07-17 | 2005-04-26 | Yale University | Inhibition of BEHAB cleavage and primary central nervous system (CNS) tumors |
| US7744888B2 (en) * | 2001-08-03 | 2010-06-29 | Abgenomics Cooperatief U.A. | Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies |
| US20040116333A1 (en) * | 2001-08-03 | 2004-06-17 | Rong-Hwa Lin | Modulators of P-selectin glycoprotein ligand 1 |
| MY148646A (en) | 2004-05-10 | 2013-05-15 | Abgenomics Cooperatief Ua | Anti-psgl-1 antibodies |
| BRPI0510561A (pt) * | 2004-05-11 | 2007-11-20 | Abgenomics Corp | epìtopos que induzem morte de célula t |
| EP2718325A4 (en) | 2011-06-13 | 2015-03-11 | ABGENOMICS COöPERATIEF U A | ANTI-PSGL-1 ANTIBODIES AND USES THEREOF |
-
2005
- 2005-05-06 MY MYPI20052048A patent/MY148646A/en unknown
- 2005-05-06 UY UY28886A patent/UY28886A1/es not_active Application Discontinuation
- 2005-05-09 AR ARP050101855A patent/AR048781A1/es active IP Right Grant
- 2005-05-10 NZ NZ590690A patent/NZ590690A/xx not_active IP Right Cessation
- 2005-05-10 CA CA2907141A patent/CA2907141C/en not_active Expired - Fee Related
- 2005-05-10 SG SG10201606541UA patent/SG10201606541UA/en unknown
- 2005-05-10 BR BRPI0510567A patent/BRPI0510567B8/pt not_active IP Right Cessation
- 2005-05-10 JP JP2007513283A patent/JP5623690B2/ja not_active Expired - Lifetime
- 2005-05-10 TW TW094115123A patent/TWI402274B/zh not_active IP Right Cessation
- 2005-05-10 NZ NZ578647A patent/NZ578647A/en not_active IP Right Cessation
- 2005-05-10 CA CA2812040A patent/CA2812040C/en not_active Expired - Fee Related
- 2005-05-10 UA UAA200612974A patent/UA100356C2/ru unknown
- 2005-05-10 SG SG2013001474A patent/SG187443A1/en unknown
- 2005-05-10 EP EP11150345.4A patent/EP2377890B1/en not_active Expired - Lifetime
- 2005-05-10 CA CA2566305A patent/CA2566305C/en not_active Expired - Lifetime
- 2005-05-10 NZ NZ551626A patent/NZ551626A/en not_active IP Right Cessation
- 2005-05-10 ES ES05747985.9T patent/ES2448468T3/es not_active Expired - Lifetime
- 2005-05-10 ES ES11150339.7T patent/ES2598034T3/es not_active Expired - Lifetime
- 2005-05-10 TW TW101128378A patent/TWI448474B/zh not_active IP Right Cessation
- 2005-05-10 KR KR1020067024896A patent/KR101256400B1/ko not_active Expired - Fee Related
- 2005-05-10 DK DK05747985.9T patent/DK1765396T3/en active
- 2005-05-10 AU AU2005244072A patent/AU2005244072C1/en not_active Expired
- 2005-05-10 EP EP11150339.7A patent/EP2377889B1/en not_active Expired - Lifetime
- 2005-05-10 PT PT57479859T patent/PT1765396E/pt unknown
- 2005-05-10 EP EP05747985.9A patent/EP1765396B1/en not_active Expired - Lifetime
- 2005-05-10 PL PL05747985T patent/PL1765396T3/pl unknown
- 2005-05-10 CN CN200580023307.2A patent/CN1984680B/zh not_active Expired - Lifetime
- 2005-05-10 CN CN201410209919.1A patent/CN103980361B/zh not_active Expired - Fee Related
- 2005-05-10 ES ES11150345.4T patent/ES2602633T3/es not_active Expired - Lifetime
- 2005-05-10 WO PCT/US2005/016357 patent/WO2005110475A2/en not_active Ceased
- 2005-05-10 MX MXPA06012986A patent/MXPA06012986A/es active IP Right Grant
- 2005-05-10 US US11/125,837 patent/US7604800B2/en active Active
- 2005-05-10 RU RU2006143686/10A patent/RU2482131C2/ru not_active Application Discontinuation
-
2006
- 2006-10-24 IL IL178838A patent/IL178838A/en active IP Right Grant
- 2006-11-08 EG EGPCTNA2006001061A patent/EG26781A/en active
- 2006-12-01 NO NO20065542A patent/NO341844B1/no not_active IP Right Cessation
- 2006-12-08 EC EC2006007056A patent/ECSP067056A/es unknown
-
2009
- 2009-03-06 US US12/399,516 patent/US20090198044A1/en not_active Abandoned
- 2009-03-06 US US12/399,484 patent/US8287871B2/en not_active Expired - Lifetime
-
2010
- 2010-08-17 US US12/858,110 patent/US8361472B2/en not_active Expired - Fee Related
-
2011
- 2011-05-30 JP JP2011121078A patent/JP2011200247A/ja active Pending
-
2012
- 2012-09-14 US US13/616,849 patent/US8663641B2/en not_active Expired - Fee Related
- 2012-09-14 US US13/616,801 patent/US8828397B2/en not_active Expired - Fee Related
-
2013
- 2013-08-20 IL IL228032A patent/IL228032A0/en unknown
- 2013-08-20 IL IL228033A patent/IL228033A0/en unknown
-
2014
- 2014-01-10 JP JP2014003463A patent/JP2014094010A/ja active Pending
- 2014-07-31 JP JP2014156064A patent/JP2014223084A/ja not_active Withdrawn
- 2014-08-11 US US14/456,279 patent/US9631019B2/en not_active Expired - Fee Related
-
2015
- 2015-02-04 PH PH12015500247A patent/PH12015500247A1/en unknown
-
2017
- 2017-03-15 US US15/459,399 patent/US10030075B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2487723C2 (ru) | Химерные и гуманизированные антитела к cd44, которые опосредствуют цитотоксичность в отношении раковых клеток | |
| RU2505603C2 (ru) | Антитело против рецептора il-6 | |
| ES2917000T3 (es) | Interferón-gamma mutante diana y usos del mismo | |
| Valent et al. | Immunotherapy-based targeting and elimination of leukemic stem cells in AML and CML | |
| US9624276B2 (en) | Peptidic chimeric antigen receptor T cell switches and uses thereof | |
| JP2007500132A5 (cg-RX-API-DMAC7.html) | ||
| AU2025263899A1 (en) | Fibroblast binding agents and use thereof | |
| HRP20201770T1 (hr) | Nova imunoterapija protiv raznih vrsta karcinoma, uključujući gastrointestinalni karcinom i gastrični karcinom | |
| RU2019119442A (ru) | Новый коньюгат аманитина | |
| CA2451353A1 (en) | Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer | |
| JP2013541335A5 (cg-RX-API-DMAC7.html) | ||
| EP2860189A3 (en) | Human cytomegalovirus neutralising antibodies and use thereof | |
| MA43330B1 (fr) | Lymphocytes t transfectés et récepteurs de lymphocytes t destinés à être utilisés en immunothérapie contre des cancers | |
| MA43328A1 (fr) | Lymphocytes t transfectés et récepteurs de lymphocytes t destinés à être utilisés en immunothérapie contre des cancers | |
| JP2015508757A5 (cg-RX-API-DMAC7.html) | ||
| EP2604693A3 (en) | TNFSF single chain molecules | |
| RU2006143686A (ru) | Антитела | |
| JP2010533498A5 (cg-RX-API-DMAC7.html) | ||
| JP2010502207A5 (cg-RX-API-DMAC7.html) | ||
| JP2006523453A5 (cg-RX-API-DMAC7.html) | ||
| NZ513498A (en) | Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases | |
| JP2012143232A5 (cg-RX-API-DMAC7.html) | ||
| FI3277321T3 (fi) | T-soluimmunoglobuliinia ja musiiniproteiini 3:a (tim-3) vastaan suunnattuja vasta-aineita | |
| JP2020500510A5 (cg-RX-API-DMAC7.html) | ||
| HRP20190799T1 (hr) | Imunocitokini na bazi il-15 i sushi domene il-15r alfa |